Fluoxymesterolone, Halo-Med, 10 mg, 120 Tabs

In Stock
55.00€
PRODUCT OVERVIEW & COMPOSITION

Brand / Manufacturer: Bioniche Pharma

Brand / Product Name: HALO-MED

Active Ingredient: Fluoxymesterone USP (10 mg per tablet)

Form & Presentation: Oral Tablets (120 tablets per container)

Pharmacological Class: Synthetic Anabolic-Androgenic Steroid ($17\alpha$-alkylated derivative of testosterone)

Bioniche Pharma HALO-MED (Fluoxymesterone) is a potent oral androgenic-anabolic agent designed to promote protein nitrogen retention and tissue accretion during severe catabolic states. When administered at therapeutic dosages alongside targeted nutritional support, Bioniche Pharma HALO-MED delivers marked anabolic support to accelerate physiological recovery without initiating early overt clinical virilization.

CLINICAL INDICATIONS & THERAPEUTIC USE

Indicated for short-term adjunctive therapy to counter nitrogen loss and muscle wasting in conditions requiring rapid tissue repair and metabolic stabilization using Bioniche Pharma products:

  • Post-surgical convalescence and recovery from major operative interventions with Bioniche Pharma anabolic support.
  • Comprehensive rehabilitation following severe traumatic injury, thermal burns, or complex bone fractures under Bioniche Pharma medical supervision.
  • Management of involuntary tissue degradation associated with prolonged infections or emaciating chronic illnesses utilizing Bioniche Pharma formulations.
  • Therapeutic intervention for cachectic states and severe debilitating conditions via Bioniche Pharma treatment protocols.
DOSAGE & ADMINISTRATION

Dosage for Bioniche Pharma HALO-MED must be strictly individualized based on clinical objectives, therapeutic response, and physician oversight. Short-term application protocols are recommended to mitigate potential hepatic and systemic secondary risks.

CONTRAINDICATIONS & PRECAUTIONS
  • Male Oncology: Contraindicated in male patients with confirmed or suspected breast carcinoma or prostatic neoplasms.
  • Pregnancy & Teratogenicity: Contraindicated in pregnant or lactating females due to high risk of fetal virilization.
  • Hepatotoxicity Risk: As a $17\alpha$-alkylated compound, continuous clinical monitoring of hepatic enzymes and lipid panels is strongly advised during course duration of Bioniche Pharma therapy.
STORAGE & HANDLING

Store Bioniche Pharma products in a cool, dry environment shielded from direct light and atmospheric moisture. Keep securely stored out of reach and sight of children.